Cargando…
Racial disparities in opioid prescription and pain management among breast cancer survivors
BACKGROUND: We examined whether there are racial disparities in pain management, opioid medicine prescriptions, symptom severity, and quality of life constructs in breast cancer survivors. METHODS: We conducted a secondary analysis of longitudinal data from the Women's Hormonal Therapy Initiati...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225217/ https://www.ncbi.nlm.nih.gov/pubmed/36916310 http://dx.doi.org/10.1002/cam4.5755 |
_version_ | 1785050352992649216 |
---|---|
author | Kim, Sunny Jung Retnam, Reuben P. Sutton, Arnethea L. Edmonds, Megan C. Bandyopadhyay, Dipankar Sheppard, Vanessa B. |
author_facet | Kim, Sunny Jung Retnam, Reuben P. Sutton, Arnethea L. Edmonds, Megan C. Bandyopadhyay, Dipankar Sheppard, Vanessa B. |
author_sort | Kim, Sunny Jung |
collection | PubMed |
description | BACKGROUND: We examined whether there are racial disparities in pain management, opioid medicine prescriptions, symptom severity, and quality of life constructs in breast cancer survivors. METHODS: We conducted a secondary analysis of longitudinal data from the Women's Hormonal Therapy Initiation and Persistence (WHIP) study (n = 595), a longitudinal study of hormonal receptor‐positive breast cancer survivors. Upon study enrollment, patients completed a survey assessing an array of psychological, behavioral, and treatment outcomes, including adjuvant endocrine therapy (AET)‐induced symptoms, and provided a saliva biospecimen. Opioid prescription records were extracted from the health maintenance organizations (HMOs) pharmacy database. The final analytic sample included women with complete HMO pharmacy records for 1 year. RESULTS: There were 251 eligible patients, of which 169 (67.3%) were White. The average age was 61.09 years old (SD = 11.07). One hundred seventy‐two patients (68.5%) had received at least one opioid medication and 37.1% were prescribed opioids longer than 90 days (n = 93). Sixty‐four Black patients (78%) had a record of being prescribed with opioids compared to 64% of White patients (n = 108, p = 0.03). Black patients reported worse vasomotor, neuropsychological, and gastrointestinal symptoms, as well as lower quality of life and greater healthcare discrimination than White patients (p's < 0.05). Black patients were more likely to be prescribed opioids for 90 days or longer compared to White patients, when controlling for age, marital status, income, body mass index (BMI), cancer stage, and chemotherapy status (adjusted Odds Ratio = 2.72, p = 0.014). CONCLUSION: Findings indicate that there are racial differences in opioid prescriptions supplied for pain management and symptomatic outcomes. Future research is needed to understand the causes of disparities in cancer pain management and symptomatic outcomes. |
format | Online Article Text |
id | pubmed-10225217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102252172023-05-29 Racial disparities in opioid prescription and pain management among breast cancer survivors Kim, Sunny Jung Retnam, Reuben P. Sutton, Arnethea L. Edmonds, Megan C. Bandyopadhyay, Dipankar Sheppard, Vanessa B. Cancer Med RESEARCH ARTICLES BACKGROUND: We examined whether there are racial disparities in pain management, opioid medicine prescriptions, symptom severity, and quality of life constructs in breast cancer survivors. METHODS: We conducted a secondary analysis of longitudinal data from the Women's Hormonal Therapy Initiation and Persistence (WHIP) study (n = 595), a longitudinal study of hormonal receptor‐positive breast cancer survivors. Upon study enrollment, patients completed a survey assessing an array of psychological, behavioral, and treatment outcomes, including adjuvant endocrine therapy (AET)‐induced symptoms, and provided a saliva biospecimen. Opioid prescription records were extracted from the health maintenance organizations (HMOs) pharmacy database. The final analytic sample included women with complete HMO pharmacy records for 1 year. RESULTS: There were 251 eligible patients, of which 169 (67.3%) were White. The average age was 61.09 years old (SD = 11.07). One hundred seventy‐two patients (68.5%) had received at least one opioid medication and 37.1% were prescribed opioids longer than 90 days (n = 93). Sixty‐four Black patients (78%) had a record of being prescribed with opioids compared to 64% of White patients (n = 108, p = 0.03). Black patients reported worse vasomotor, neuropsychological, and gastrointestinal symptoms, as well as lower quality of life and greater healthcare discrimination than White patients (p's < 0.05). Black patients were more likely to be prescribed opioids for 90 days or longer compared to White patients, when controlling for age, marital status, income, body mass index (BMI), cancer stage, and chemotherapy status (adjusted Odds Ratio = 2.72, p = 0.014). CONCLUSION: Findings indicate that there are racial differences in opioid prescriptions supplied for pain management and symptomatic outcomes. Future research is needed to understand the causes of disparities in cancer pain management and symptomatic outcomes. John Wiley and Sons Inc. 2023-03-14 /pmc/articles/PMC10225217/ /pubmed/36916310 http://dx.doi.org/10.1002/cam4.5755 Text en © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | RESEARCH ARTICLES Kim, Sunny Jung Retnam, Reuben P. Sutton, Arnethea L. Edmonds, Megan C. Bandyopadhyay, Dipankar Sheppard, Vanessa B. Racial disparities in opioid prescription and pain management among breast cancer survivors |
title | Racial disparities in opioid prescription and pain management among breast cancer survivors |
title_full | Racial disparities in opioid prescription and pain management among breast cancer survivors |
title_fullStr | Racial disparities in opioid prescription and pain management among breast cancer survivors |
title_full_unstemmed | Racial disparities in opioid prescription and pain management among breast cancer survivors |
title_short | Racial disparities in opioid prescription and pain management among breast cancer survivors |
title_sort | racial disparities in opioid prescription and pain management among breast cancer survivors |
topic | RESEARCH ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225217/ https://www.ncbi.nlm.nih.gov/pubmed/36916310 http://dx.doi.org/10.1002/cam4.5755 |
work_keys_str_mv | AT kimsunnyjung racialdisparitiesinopioidprescriptionandpainmanagementamongbreastcancersurvivors AT retnamreubenp racialdisparitiesinopioidprescriptionandpainmanagementamongbreastcancersurvivors AT suttonarnetheal racialdisparitiesinopioidprescriptionandpainmanagementamongbreastcancersurvivors AT edmondsmeganc racialdisparitiesinopioidprescriptionandpainmanagementamongbreastcancersurvivors AT bandyopadhyaydipankar racialdisparitiesinopioidprescriptionandpainmanagementamongbreastcancersurvivors AT sheppardvanessab racialdisparitiesinopioidprescriptionandpainmanagementamongbreastcancersurvivors |